CPHA Canvax
AUDIOVISUAL

"The Public Health Agency of Canada, Thrombosis Canada and the National Collaborating Centre for Infectious Diseases (NCCID) present a webinar to inform health care providers on the treatment and reporting of Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)." - PHAC: COVID-19 Vaccine Emerging Issues Webinar: Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)


Web link

PHAC: COVID-19 Vaccine Emerging Issues Webinar: Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

Related Resources

Bookmark

Implementation Tool

Audiovisual

Category

Vaccine Safety and Development,Vaccine Safety,Adverse Events Following Immunization (AEFI),Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.